Clinical Trial Update: A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC

View source ↗

Summary

A completed real-world study assessed the effectiveness of nivolumab plus chemotherapy as neoadjuvant therapy for non-small cell lung cancer. The update provide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-small Cell Lung Cancer (NSCLC) | Status: COMPLETED